RxSight, Inc. (RXST) Social Stream
RXSIGHT INC (RXST) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RXST.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-22 | 5 | $28 | $17 | $20.6 | $26.75 | -22.99% |
| 2021-11-11 | 4 | $28 | $18 | $21.5 | $26.75 | -19.63% |
| 2022-02-02 | 4 | $28 | $16 | $20.5 | $26.75 | -23.36% |
| 2022-03-09 | 4 | $28 | $15 | $19.75 | $26.75 | -26.17% |
| 2022-05-06 | 5 | $28 | $15 | $19.4 | $26.75 | -27.48% |
| 2022-08-09 | 4 | $28 | $17 | $21.75 | $26.75 | -18.69% |
| 2022-11-08 | 3 | $22 | $15 | $18 | $26.75 | -32.71% |
| 2023-03-03 | 4 | $22 | $14 | $18.25 | $26.75 | -31.78% |
| 2023-03-08 | 4 | $22 | $14 | $19.75 | $26.75 | -26.17% |
| 2023-04-19 | 5 | $23 | $14 | $20 | $26.75 | -25.23% |
| 2023-05-15 | 5 | $27 | $17 | $23 | $26.75 | -14.02% |
| 2023-06-06 | 6 | $29 | $17 | $24 | $26.75 | -10.28% |
| 2023-06-21 | 6 | $29 | $23 | $26.5 | $26.75 | -0.93% |
| 2023-07-07 | 6 | $32 | $23 | $27.833 | $26.75 | 4.05% |
| 2023-07-12 | 6 | $34 | $23 | $29 | $26.75 | 8.41% |
| 2023-08-07 | 6 | $36 | $23 | $30.166 | $26.75 | 12.77% |
| 2023-08-08 | 6 | $36 | $23 | $31 | $26.75 | 15.89% |
| 2023-08-13 | 6 | $36 | $27 | $32.333 | $26.75 | 20.87% |
The Trend in the Analyst Price Target
Over the past 15 months, RXST's average price target has gone up $12.93.
Over the past 44 weeks, RXST's average upside potential has been 20.92%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-08 | 3 | 22 | 15 | 18.00 | 13.47 | 33.63% |
| 2023-03-03 | 4 | 22 | 14 | 18.25 | 13.89 | 31.39% |
| 2023-03-08 | 4 | 22 | 14 | 19.25 | 14.98 | 28.5% |
| 2023-04-13 | 5 | 23 | 14 | 20.00 | 17.87 | 11.92% |
| 2023-05-15 | 5 | 27 | 17 | 23.00 | 22.64 | 1.59% |
RXST Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 4 | 1 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
RXST's average broker recommendation rating worsened by 0.17 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RXSIGHT INC's upside potential (average analyst target price relative to current price) is higher than 235.73% of all US stocks.
- In terms of how RXSIGHT INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 560.36% of that group.
- To contextualize these metrics, consider that out of Medical Equipment stocks, RXSIGHT INC's average analyst price target is higher than 858.68% of them.
- RXST has a lower variance in analysts' estimates than -980.21% of Healthcare stocks.
Stocks similar to RXSIGHT INC in the Medical Equipment industry regarding analyst recommendations and price targets are CHEK, BBLG, and CLGN.
View All Top Stocks by Price Target
Is RXST a Buy, Hold or Sell? See the POWR Ratings now!